- Filed
- May 16, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2022 · Mar 31, 2022 | 80.26M sh |
| Capex | Q1 2022 · Mar 31, 2022 | $0 |
| Capex | Q1 2022 · Mar 31, 2021 | $0 |
| Cash And Equivalents | Q1 2022 · Mar 31, 2022 | $6.1K |
| Cash And Equivalents | Q1 2022 · Dec 31, 2021 | $11.6K |
| Cash And Equivalents | Q1 2022 · Mar 31, 2021 | $2.18K |
| Cash And Equivalents | Q1 2022 · Dec 31, 2020 | $3.03K |
| Total Liabilities | Q1 2022 · Mar 31, 2022 | $8.38K |
| Total Liabilities | Q1 2022 · Dec 31, 2021 | $7.5K |
| Current Assets | Q1 2022 · Mar 31, 2022 | $6.1K |
| Current Assets | Q1 2022 · Dec 31, 2021 | $11.6K |
| Total Assets | Q1 2022 · Mar 31, 2022 | $6.5K |
| Total Assets | Q1 2022 · Dec 31, 2021 | $12K |
| Operating Cash Flow | Q1 2022 · Mar 31, 2021 | −$12.75K |
| Stockholders Equity | Q1 2022 · Mar 31, 2021 | −$19.22K |
| Stockholders Equity | Q1 2022 · Dec 31, 2020 | −$6.47K |
| Sga Expense restated | Q1 2022 · Mar 31, 2021 | $1K |
| Net Income | Q1 2022 · Mar 31, 2021 | −$12.75K |
| Revenue | Q1 2022 · Mar 31, 2021 | $0 |